Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-043522
Filing Date
2019-11-14
Accepted
2019-11-14 16:16:37
Documents
62
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ck0001734517-10q_20190930.htm 10-Q 2730842
2 EX-31.1 ck0001734517-ex311_8.htm EX-31.1 18936
3 EX-31.2 ck0001734517-ex312_9.htm EX-31.2 18867
4 EX-32.1 ck0001734517-ex321_6.htm EX-32.1 9205
5 EX-32.2 ck0001734517-ex322_7.htm EX-32.2 9273
  Complete submission text file 0001564590-19-043522.txt   7187546

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ck0001734517-20190930.xml EX-101.INS 1206663
7 XBRL TAXONOMY EXTENSION SCHEMA ck0001734517-20190930.xsd EX-101.SCH 45534
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0001734517-20190930_cal.xml EX-101.CAL 34515
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0001734517-20190930_def.xml EX-101.DEF 194741
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001734517-20190930_lab.xml EX-101.LAB 389185
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001734517-20190930_pre.xml EX-101.PRE 311979
Mailing Address 1 MEDIMMUNE WAY GAITHERSBURG MD 20878
Business Address 1 MEDIMMUNE WAY GAITHERSBURG MD 20878 240-780-6356
Viela Bio, Inc. (Filer) CIK: 0001734517 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39067 | Film No.: 191220413
SIC: 2834 Pharmaceutical Preparations